Mymetics Corporation (MYMX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jul 11, 2025
Mymetics Revenue
Mymetics had revenue of 34.00K EUR in the quarter ending September 30, 2023, a decrease of -73.85%. This brings the company's revenue in the last twelve months to 533.00K, down -44.71% year-over-year. In the year 2022, Mymetics had annual revenue of 1.03M with 139.07% growth.
Revenue (ttm)
533.00K EUR
Revenue Growth
-44.71%
P/S Ratio
0.00
Revenue / Employee
266.50K EUR
Employees
2
Market Cap
46.00 USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 1.03M | 598.00K | 139.07% |
Dec 31, 2021 | 430.00K | -238.00K | -35.63% |
Dec 31, 2020 | 668.00K | 15.00K | 2.30% |
Dec 31, 2019 | 653.00K | -314.00K | -32.47% |
Dec 31, 2018 | 967.00K | -548.00K | -36.17% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |